YieldMax(R) ETFs Announces Distributions on MSST, NVIT, and TEST GlobeNewswire December 08, 2025 CHICAGO and MILWAUKEE and NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — YieldMax(R) today announced distributions for the YieldMax(R) Performance & Distribution Target 25(TM) ETFs listed in the table below. The Fund seeks to generate income with a 25% target annual income […]
Shenzhen, Dec. 08, 2025 (GLOBE NEWSWIRE) — With the final results officially announced on December 6, LiTime “Go Electric” Contest has successfully wrapped up. Launched on September 5, the Contest received over 500 submissions by November 26, attracted more than 25,000 page views, and saw over 3,000 votes cast. Ultimately, 58 winners shared a total
From Paddle to Power: LiTime “Go Electric” Contest Concludes, Driving a Global Wave of Boating Electrification GlobeNewswire December 08, 2025 Shenzhen, Dec. 08, 2025 (GLOBE NEWSWIRE) — With the final results officially announced on December 6, LiTime “Go Electric” Contest has successfully wrapped up. Launched on September 5, the Contest received over 500 submissions by
SINGAPORE , Dec. 08, 2025 (GLOBE NEWSWIRE) — The official IEO of T5 blockchain's first native token — will be F5($F5) on Coinstore's spot trading platform. The token is set to be listed as the F5/USDT pair, and will begin trading on the 12th of December 2025, after the private sale goes live on 9th
T5 Blockchain Launches its first Risk Shield Asset in an Initial Exchange Offering on Coinstore: F(5) Dec 2025 GlobeNewswire December 08, 2025 SINGAPORE , Dec. 08, 2025 (GLOBE NEWSWIRE) — The official IEO of T5 blockchain's first native token — will be F5($F5) on Coinstore's spot trading platform. The token is set to be listed
(NYSE:CODI), WESTPORT, Conn., Dec. 08, 2025 (GLOBE NEWSWIRE) — Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market branded consumer and industrial businesses, today announced the filing of its restated financial results for fiscal years 2022, 2023, and 2024 and the financial information for each of the interim periods included within
(NASDAQ:SNDX), – First real-world evidence for a menin inhibitor shows 77% ORR (10/13), 31% (4/13) CR/CRh, 75% (9/12) MRD negativity, and favorable tolerability among primarily R/R NPM1m, KMT2Ar, and NUP98r acute leukemia pts – – Retrospective review shows revumenib was well tolerated as post-HSCT maintenance in children with KMT2Ar and NUP98r; all pts were alive
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — RentRedi, the fastest-growing property management software for smart real estate investors, today announced the launch of its new Spanish-language version of the RentRedi Tenant App. The new release empowers landlords to better serve Spanish-speaking renters by offering a fully translated tenant experience for core renting tasks including
Compass Diversified Completes Restatement of Previously Issued Financial Statements GlobeNewswire December 08, 2025 WESTPORT, Conn., Dec. 08, 2025 (GLOBE NEWSWIRE) — Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market branded consumer and industrial businesses, today announced the filing of its restated financial results for fiscal years 2022, 2023, and 2024
Syndax Highlights Leadership in Menin Inhibition at ASH 2025 with Multiple Revuforj(R) (revumenib) Presentations Spanning the Acute Leukemia Treatment Continuum GlobeNewswire December 08, 2025 – First real-world evidence for a menin inhibitor shows 77% ORR (10/13), 31% (4/13) CR/CRh, 75% (9/12) MRD negativity, and favorable tolerability among primarily R/R NPM1m, KMT2Ar, and NUP98r acute leukemia